Literature DB >> 29027381

Evaluation of a new energy device for parenchymal transection in laparoscopic liver resection.

Amr Badawy1,2, Satoru Seo1, Rei Toda1, Hiroaki Fuji1, Takamichi Ishii1, Kojiro Taura1, Kentaro Yasuchika1, Toshimi Kaido1, Shinji Uemoto1.   

Abstract

INTRODUCTION: THUNDERBEAT (TB) is a novel device that uses both ultrasonic and advanced bipolar energies for hemostasis. Several recent human studies have proved the safety and efficacy of TB in different surgical procedures, but there have been no similar studies about its efficacy in hepatic parenchymal transection. Therefore, the aim of the study was to assess the safety and efficacy of the TB device in laparoscopic liver resection.
METHODS: This retrospective study compared TB and ultrasonic Harmonic devices in 80 patients who underwent laparoscopic liver resection from 2010 to 2016 in our institution. To reduce the selection bias, the two groups were matched in a 1-to-2 ratio on the basis of propensity scores.
RESULTS: There were no differences in the preoperative patient characteristics between the two groups. The extent of liver resection was comparable between the groups. Although the Harmonic group's intraoperative blood loss and operative time were less than that of the TB group, the differences were not statistically significant (P = 0.08, P = 0.32, respectively). Postoperative complications, mortality within 90 days, and hospital stay were comparable between the two groups.
CONCLUSION: TB is as safe and effective for parenchymal transection in laparoscopic hepatectomy as ultrasonic devices, but it is not a superior alternative.
© 2017 Japan Society for Endoscopic Surgery, Asia Endosurgery Task Force and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Laparoscopic surgery; THUNDERBEAT device; liver resection

Mesh:

Year:  2017        PMID: 29027381     DOI: 10.1111/ases.12432

Source DB:  PubMed          Journal:  Asian J Endosc Surg        ISSN: 1758-5902


  3 in total

1.  The Italian Consensus on minimally invasive simultaneous resections for synchronous liver metastasis and primary colorectal cancer: A Delphi methodology.

Authors:  Aldo Rocca; Federica Cipriani; Paolo Delrio; Fulvio Calise; Luca Aldrighetti; Giulio Belli; Stefano Berti; Ugo Boggi; Vincenzo Bottino; Umberto Cillo; Matteo Cescon; Matteo Cimino; Francesco Corcione; Luciano De Carlis; Maurizio Degiuli; Paolo De Paolis; Agostino Maria De Rose; Domenico D'Ugo; Fabrizio Di Benedetto; Ugo Elmore; Giorgio Ercolani; Giuseppe M Ettorre; Alessandro Ferrero; Marco Filauro; Felice Giuliante; Salvatore Gruttadauria; Alfredo Guglielmi; Francesco Izzo; Elio Jovine; Andrea Laurenzi; Francesco Marchegiani; Pierluigi Marini; Marco Massani; Vincenzo Mazzaferro; Michela Mineccia; Francesco Minni; Andrea Muratore; Simone Nicosia; Riccardo Pellicci; Riccardo Rosati; Nadia Russolillo; Antonino Spinelli; Gaya Spolverato; Guido Torzilli; Giovanni Vennarecci; Luca Viganò; Leonardo Vincenti
Journal:  Updates Surg       Date:  2021-06-05

2.  Thunderbeat™ Integrated Bipolar and Ultrasonic Forceps in the Whipple Procedure: A Prospective Randomized Trial.

Authors:  C Alston James; Gregory A Williams; Linda X Jin; Jingxia Liu; Dominic E Sanford; Ryan C Fields; Majella M B Doyle; Steven M Strasberg; William G Hawkins; Chet W Hammill
Journal:  Mo Med       Date:  2020 Nov-Dec

3.  Evaluation of THUNDERBEAT® in open liver resection- a single-center experience.

Authors:  Bibek Aryal; Teruo Komokata; Hiroto Yasumura; Daisaku Kamiimabeppu; Maki Inoue; Kota Yoshikawa; Mamoru Kaieda; Yutaka Imoto
Journal:  BMC Surg       Date:  2018-10-16       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.